ReP USP - Resultado da busca

Artigo de periodico
Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model (2009)
Carneiro Lobo, Tatiana Correa; Konig, Sandra; Machado, D. E.; Nasciutti, Luiz Eurico; Forni, Maria F.; Francischetti, I. M. B.; Sogayar, Mari Cleide ; Monteiro, Robson de Queiroz
Source: Journal of Thrombosis and Haemostasis. Unidade: IQ
Subjects: ANTICOAGULANTES (TERAPIA), BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO LOBO, Tatiana Correa et al. Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model. Journal of Thrombosis and Haemostasis, v. 7, n. 11, p. 1855-1864, 2009Tradução . . Disponível em: https://doi.org/10.1111/j.1538-7836.2009.03553.x. Acesso em: 04 out. 2024.
APA
Carneiro Lobo, T. C., Konig, S., Machado, D. E., Nasciutti, L. E., Forni, M. F., Francischetti, I. M. B., et al. (2009). Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model. Journal of Thrombosis and Haemostasis, 7( 11), 1855-1864. doi:10.1111/j.1538-7836.2009.03553.x
NLM
Carneiro Lobo TC, Konig S, Machado DE, Nasciutti LE, Forni MF, Francischetti IMB, Sogayar MC, Monteiro R de Q. Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model [Internet]. Journal of Thrombosis and Haemostasis. 2009 ; 7( 11): 1855-1864.[citado 2024 out. 04 ] Available from: https://doi.org/10.1111/j.1538-7836.2009.03553.x
Vancouver
Carneiro Lobo TC, Konig S, Machado DE, Nasciutti LE, Forni MF, Francischetti IMB, Sogayar MC, Monteiro R de Q. Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model [Internet]. Journal of Thrombosis and Haemostasis. 2009 ; 7( 11): 1855-1864.[citado 2024 out. 04 ] Available from: https://doi.org/10.1111/j.1538-7836.2009.03553.x
Artigo de periodico
Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies (2008)
Anstee, Q. M.; Goldin, R. D.; Wright, M.; Martinelli, A
Source: Journal of Thrombosis and Haemostasis. Unidade: FMRP
Subjects: HEPATITE (TRATAMENTO), COAGULAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANSTEE, Q. M. et al. Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies. Journal of Thrombosis and Haemostasis, v. 6, n. 8, p. 1336-1343, 2008Tradução . . Disponível em: https://doi.org/10.1111/j.1538-7836.2008.03015.x. Acesso em: 04 out. 2024.
APA
Anstee, Q. M., Goldin, R. D., Wright, M., & Martinelli, A. (2008). Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies. Journal of Thrombosis and Haemostasis, 6( 8), 1336-1343. doi:10.1111/j.1538-7836.2008.03015.x
NLM
Anstee QM, Goldin RD, Wright M, Martinelli A. Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies [Internet]. Journal of Thrombosis and Haemostasis. 2008 ; 6( 8): 1336-1343.[citado 2024 out. 04 ] Available from: https://doi.org/10.1111/j.1538-7836.2008.03015.x
Vancouver
Anstee QM, Goldin RD, Wright M, Martinelli A. Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies [Internet]. Journal of Thrombosis and Haemostasis. 2008 ; 6( 8): 1336-1343.[citado 2024 out. 04 ] Available from: https://doi.org/10.1111/j.1538-7836.2008.03015.x
Artigo de periodico
A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease (2004)
Hovinga, J. A. Kremer; Franco, R. F.; Zago, Marco Antônio; Cate, Hugo Ten; Westendorp, R. G. J.; Reitsma, P. H.
Source: Journal of Thrombosis and Haemostasis. Unidade: FMRP
Assunto: HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOVINGA, J. A. Kremer et al. A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease. Journal of Thrombosis and Haemostasis, v. 2, p. 54-57, 2004Tradução . . Disponível em: https://doi.org/10.1111/j.1538-7836.2004.00557.x. Acesso em: 04 out. 2024.
APA
Hovinga, J. A. K., Franco, R. F., Zago, M. A., Cate, H. T., Westendorp, R. G. J., & Reitsma, P. H. (2004). A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease. Journal of Thrombosis and Haemostasis, 2, 54-57. doi:10.1111/j.1538-7836.2004.00557.x
NLM
Hovinga JAK, Franco RF, Zago MA, Cate HT, Westendorp RGJ, Reitsma PH. A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease [Internet]. Journal of Thrombosis and Haemostasis. 2004 ; 2 54-57.[citado 2024 out. 04 ] Available from: https://doi.org/10.1111/j.1538-7836.2004.00557.x
Vancouver
Hovinga JAK, Franco RF, Zago MA, Cate HT, Westendorp RGJ, Reitsma PH. A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease [Internet]. Journal of Thrombosis and Haemostasis. 2004 ; 2 54-57.[citado 2024 out. 04 ] Available from: https://doi.org/10.1111/j.1538-7836.2004.00557.x
Trabalho de evento-resumo periodico
Procoagulant effects of raloxifene in postmenopausal women (2003)
Franco, Rendrik França; Baggio, M. S.; Sala, Maria Matheus de; Sá, Marcos Felipe Silva de; Azevedo, G. D.
Source: Journal of Thrombosis and Haemostasis. Conference titles: Congress of the International Society on Thrombosis and Haemostasis. Unidade: FMRP
Subjects: MENOPAUSA (EFEITOS DE DROGAS), TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCO, Rendrik França et al. Procoagulant effects of raloxifene in postmenopausal women. Journal of Thrombosis and Haemostasis. Malden: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 04 out. 2024. , 2003
APA
Franco, R. F., Baggio, M. S., Sala, M. M. de, Sá, M. F. S. de, & Azevedo, G. D. (2003). Procoagulant effects of raloxifene in postmenopausal women. Journal of Thrombosis and Haemostasis. Malden: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Franco RF, Baggio MS, Sala MM de, Sá MFS de, Azevedo GD. Procoagulant effects of raloxifene in postmenopausal women. Journal of Thrombosis and Haemostasis. 2003 ; 1[citado 2024 out. 04 ]
Vancouver
Franco RF, Baggio MS, Sala MM de, Sá MFS de, Azevedo GD. Procoagulant effects of raloxifene in postmenopausal women. Journal of Thrombosis and Haemostasis. 2003 ; 1[citado 2024 out. 04 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em